Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

363
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
363
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

686
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
686
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

254
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
254
Drug Therapy01:28

Drug Therapy

92
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
92
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

235
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
235
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Neuropathology in genetic Parkinson's disease: a focused review of pathological and clinical findings.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Choreiform Wilson's disease and a distinctive 7-Tesla magnetic resonance imaging finding.

Arquivos de neuro-psiquiatria·2026
Same author

Deep brain stimulation for dystonia: outcomes from a Brazilian cohort.

Arquivos de neuro-psiquiatria·2026
Same author

Neuropathology in genetic Parkinson's disease: a focused review of pathological and clinical findings.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.

Arquivos de neuro-psiquiatria·2025
Same author

Sixty years of the first studies by Horácio Martins Canelas on Wilson's disease.

Arquivos de neuro-psiquiatria·2025

Related Experiment Video

Updated: Sep 1, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K

How I treat Parkinson's disease.

Egberto Reis Barbosa1, João Carlos Papaterra Limongi1, Hsin Fen Chien1

  • 1Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia, Grupo de Distúrbios do Movimento, São Paulo, SP, Brazil.

Arquivos De Neuro-Psiquiatria
|August 17, 2022
PubMed
Summary

Tailored treatment and regular exercise are key for Parkinson's disease (PD) management. Strategies should prioritize functional capacity and quality of life across all disease stages, from early to advanced.

More Related Videos

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.5K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K

Related Experiment Videos

Last Updated: Sep 1, 2025

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.0K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.5K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K

Area of Science:

  • Neurology
  • Neurodegenerative Diseases

Background:

  • Parkinson's disease (PD) is a complex neurodegenerative disorder.
  • Effective treatment strategies across all disease stages are vital for managing quality of life and preventing complications.

Purpose of the Study:

  • To review current treatment approaches for Parkinson's disease.
  • To cover therapeutic interventions from early to advanced stages of the condition.

Main Methods:

  • A comprehensive literature review was performed.
  • The review focused on the treatment of Parkinson's disease at different stages of progression.

Main Results:

  • Regular exercise is recommended for all individuals diagnosed with PD.
  • Early-stage treatment involves optimizing levodopa dosage to maximize function while minimizing risks like dyskinesias and impulse control disorders.
  • In moderate to advanced stages, managing motor fluctuations and treatment complications is crucial for maintaining quality of life. Rehabilitation programs can improve motor symptoms at any stage.

Conclusions:

  • Treatment decisions for PD must consider disease progression, risk factors for complications, and potential side effects.
  • The primary goals of Parkinson's disease treatment are to maintain functional capacity and enhance quality of life throughout the disease course.